Acrodermatitis chronica atrophicans laboratory findings: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{CMG}}; {{AE}} {{RT}} | {{CMG}}; {{AE}} {{ANahita}} {{RT}} | ||
{{ACA}} | {{ACA}} | ||
==Overview== | |||
An elevated/reduced concentration of serum/blood/urinary/CSF/other [lab test] is diagnostic of [[acrodermatitis chronica atrophicans]]. | |||
==Laboratory Findings== | ==Laboratory Findings== | ||
* Physicians | *[[Physicians]] can use [[serology|serologic]] and [[histology|histologic]] examination to confirm the [[diagnosis]] of [[acrodermatitis chronica atrophicans]]. | ||
* Biopsy shows [[inflammation#Chronic inflammation|chronic inflammatory]] signs in | *High anti-[[Spirochaete|spirochetal]] [[antibody]] levels has been detected at indirect [[immunofluorescence]] and [[enzyme linked immunosorbent assay (ELISA)]].<ref name="pmid3577484">{{cite journal| author=Asbrink E, Hovmark A, Olsson I| title=Clinical manifestations of acrodermatitis chronica atrophicans in 50 Swedish patients. | journal=Zentralbl Bakteriol Mikrobiol Hyg A | year= 1986 | volume= 263 | issue= 1-2 | pages= 253-61 | pmid=3577484 | doi=10.1016/s0176-6724(86)80128-6 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3577484 }} </ref> | ||
*[[Biopsy]] shows [[inflammation#Chronic inflammation|chronic inflammatory]] signs in [[Chronic (medical)|chronic cases]]. <ref name="pmid22153213">{{cite journal |author=Rosenlund S, Bækgaard N, Menné T |title=[Acrodermatitis chronica atrophicans can be difficult to diagnose] |language=Danish |journal=Ugeskr. Laeg. |volume=173 |issue=50 |pages=3272–3 |year=2011 |month=December |pmid=22153213 |doi= |url=}}</ref> | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
Revision as of 10:54, 3 June 2021
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Template:ANahita Raviteja Guddeti, M.B.B.S. [2]
|
Acrodermatitis chronica atrophicans Microchapters |
|
Differentiating Acrodermatitis chronica atrophicans from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Acrodermatitis chronica atrophicans laboratory findings On the Web |
|
American Roentgen Ray Society Images of Acrodermatitis chronica atrophicans laboratory findings |
|
FDA on Acrodermatitis chronica atrophicans laboratory findings |
|
CDC on Acrodermatitis chronica atrophicans laboratory findings |
|
Acrodermatitis chronica atrophicans laboratory findings in the news |
|
Blogs on Acrodermatitis chronica atrophicans laboratory findings |
|
Risk calculators and risk factors for Acrodermatitis chronica atrophicans laboratory findings |
Overview
An elevated/reduced concentration of serum/blood/urinary/CSF/other [lab test] is diagnostic of acrodermatitis chronica atrophicans.
Laboratory Findings
- Physicians can use serologic and histologic examination to confirm the diagnosis of acrodermatitis chronica atrophicans.
- High anti-spirochetal antibody levels has been detected at indirect immunofluorescence and enzyme linked immunosorbent assay (ELISA).[1]
- Biopsy shows chronic inflammatory signs in chronic cases. [2]
References
- ↑ Asbrink E, Hovmark A, Olsson I (1986). "Clinical manifestations of acrodermatitis chronica atrophicans in 50 Swedish patients". Zentralbl Bakteriol Mikrobiol Hyg A. 263 (1–2): 253–61. doi:10.1016/s0176-6724(86)80128-6. PMID 3577484.
- ↑ Rosenlund S, Bækgaard N, Menné T (2011). "[Acrodermatitis chronica atrophicans can be difficult to diagnose]". Ugeskr. Laeg. (in Danish). 173 (50): 3272–3. PMID 22153213. Unknown parameter
|month=ignored (help)